Osteonic오스테오닉
226400 · KOSDAQ · ₩226400 · 오스테오닉
₩4,260▲ ₩85 (2.04%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩45B | ₩34B | ₩28B | ₩20B | ₩16B |
| Cost of sales | ₩23B | ₩17B | ₩15B | ₩11B | ₩9.1B |
| Gross profit | ₩22B | ₩17B | ₩13B | ₩8.7B | ₩6.5B |
| Operating income | ₩8.9B | ₩6.9B | ₩4.8B | ₩2.5B | ₩579M |
| Net income | ₩7.5B | ₩5.6B | ₩3.7B | ₩836M | −₩2.9B |
| Net income to shareholders | ₩7.5B | ₩5.6B | ₩3.7B | ₩836M | −₩2.9B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩100B | ₩90B | ₩72B | ₩62B | ₩64B |
| Current assets | ₩59B | ₩54B | ₩40B | ₩37B | ₩41B |
| Cash and equivalents | ₩14B | ₩10B | ₩4.1B | ₩12B | ₩9.4B |
| Total liabilities | ₩33B | ₩31B | ₩20B | ₩25B | ₩29B |
| Current liabilities | ₩20B | ₩17B | ₩12B | ₩20B | ₩25B |
| Borrowings | ₩18B | ₩15B | ₩4.3B | ₩12B | ₩13B |
| Total equity | ₩68B | ₩59B | ₩52B | ₩37B | ₩36B |
| Shareholders' equity | ₩67B | ₩59B | ₩52B | ₩37B | ₩36B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩9B | ₩4.7B | ₩4.1B | ₩4B | ₩2.9B |
| Capital spending | ₩8.7B | ₩5.2B | ₩6.1B | ₩481M | ₩939M |
| Free cash flow | ₩324M | −₩453M | −₩2B | ₩3.5B | ₩2B |
Consolidated where available. Amounts in won.
Also known as: Osteonic / 오스테오닉 / 226400 / KRX:226400
Source: KRX statistical information